CIK: 0001646343
Total reported value
$120.1M
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | PFE | Pfizer INC | Stock-Healthcare | 13.70% | — | +146.83% | |
| 2 | ✓ | Shire PLC | Stock-Other | 9.25% | — | -20.00% | |
| 3 | AZNN | Astrazeneca Plc-spons Adr | Stock-Other | 7.79% | — | +63.33% | |
| 4 | CELG | Celgene CORP | Stock-Other | 7.62% | — | -1.64% | |
| 5 | GSK | GSK plc ADRhedged | Stock-Healthcare | 6.81% | — | — | |
| 6 | VRTX | Vertex Pharmaceuticals INC | Stock-Healthcare | 5.58% | — | — | |
| 7 | ALXN | Alexion Pharmaceuticals INC | Stock-Other | 5.35% | — | -13.50% | |
| 8 | KRG | Kite Realty Group Trust | Stock-Real Estate | 4.21% | — | -30.00% | |
| 9 | T8S | Tesaro INC | Stock-Other | 3.93% | — | — | |
| 10 | ✓ | Neuroderm LTD | Stock-Other | 3.90% | — | — | |
| 11 | GBTUSD | Global Blood Therapeutics In | Stock-Other | 3.85% | +0.64% | +240.83% | |
| 12 | VNDA | Vanda Pharmaceuticals INC | Stock-Other | 3.66% | — | — | |
| 13 | ARRYEUR | Array Biopharma INC | Stock-Other | 3.65% | — | — | |
| 14 | NERVGBP | Minerva Neurosciences INC | Stock-Other | 3.13% | — | +53.60% | |
| 15 | NLNKEUR | Lumos Pharma INC | Stock-Other | 2.46% | — | — | |
| 16 | CARAEUR | Cara Therapeutics INC | Stock-Other | 1.83% | — | -22.00% | |
| 17 | ACRS | Aclaris Therapeutics INC | Stock-Other | 1.70% | — | — | |
| 18 | CLDNEUR | Eiger Biopharmaceuticals INC | Stock-Other | 1.54% | — | — | |
| 19 | PRTKEUR | Paratek Pharmaceuticals INC | Stock-Other | 1.47% | — | +50.00% | |
| 20 | ✓ | Ignyta INC | Stock-Other | 1.47% | — | — | |
| 21 | ABEO1EUR | Abeona Therapeutics INC | Stock-Other | 1.26% | — | -13.10% | |
| 22 | AXSM | Axsome Therapeutics INC | Stock-Healthcare | 0.80% | — | — | |
| 23 | ✓ | Axovant Sciences LTD | Stock-Other | 0.76% | — | — | |
| 24 | ✓ | Tigenix | Stock-Other | 0.73% | — | — | |
| 25 | MRNSUSD | Marinus Pharmaceuticals INC | Stock-Other | 0.72% | — | — | |
| 26 | CLSDUSD | Clearside Biomedical INC | Stock-Other | 0.49% | — | — | |
| 27 | ZSANGBP | Zosano Pharma CORP | Stock-Other | 0.48% | — | — | |
| 28 | ✓ | Advaxis | Stock-Other | 0.40% | — | -51.60% | |
| 29 | ✓ | Veralto CORP | Stock-Other | 0.36% | — | — | |
| 30 | SRRAEUR | Sierra Oncology INC | Stock-Other | 0.31% | — | — | |
| 31 | ALKS | Alkermes plc | Stock-Healthcare | 0.28% | — | — | |
| 32 | ✓ | Obseva SA | Stock-Other | 0.27% | — | — | |
| 33 | VTGNUSD | Vistagen Therapeutics INC | Stock-Other | 0.14% | — | — | |
| 34 | ✓ | Stock-Other | 0.09% | — | — | ||
| 35 | ✓ | Steadymed LTD | Stock-Other | 0.02% | — | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | PFE | Pfizer INC | +7.6% | +146.83% | Add |
| 2 | GBTUSD | Global Blood Therapeutics In | +3.3% | +240.83% | Add |
| 3 | AZNN | Astrazeneca Plc-spons Adr | +3% | +63.33% | Add |
| 4 | PRTKEUR | Paratek Pharmaceuticals INC | +0.6% | +50.00% | Add |
| 5 | CARAEUR | Cara Therapeutics INC | +0.5% | -22.00% | Trim |
| 6 | KRG | Kite Realty Group Trust | +0.3% | -30.00% | Trim |
| 7 | ✓ | Veralto CORP | +0.1% | — | Unchanged |
| 8 | NERVGBP | Minerva Neurosciences INC | -0.3% | +53.60% | Add |
| 9 | ✓ | Advaxis | -0.4% | -51.60% | Trim |
| 10 | CELG | Celgene CORP | -0.7% | -1.64% | Trim |
| 11 | ALXN | Alexion Pharmaceuticals INC | -1.8% | -13.50% | Trim |
| 12 | ✓ | Shire PLC | -3.7% | -20.00% | Trim |
| 13 | NVS | Novartis Ag-sponsored Adr | — | EXIT | Sold out |
| 14 | GSK | GSK plc ADRhedged | — | NEW | New buy |
| 15 | VRTX | Vertex Pharmaceuticals INC | — | NEW | New buy |
| 16 | ✓ | Horizon Pharma PLC | — | EXIT | Sold out |
| 17 | T8S | Tesaro INC | — | NEW | New buy |
| 18 | ✓ | Neuroderm LTD | — | NEW | New buy |
| 19 | VNDA | Vanda Pharmaceuticals INC | — | NEW | New buy |
| 20 | ARRYEUR | Array Biopharma INC | — | NEW | New buy |
| 21 | AZN | AstraZeneca PLC | — | EXIT | Sold out |
| 22 | ✓ | Tesaro INC | — | EXIT | Sold out |
| 23 | ALNY | Alnylam Pharmaceuticals INC | — | EXIT | Sold out |
| 24 | NLNKEUR | Lumos Pharma INC | — | NEW | New buy |
| 25 | NBIX | Neurocrine Biosciences INC | — | EXIT | Sold out |
| 26 | XLRN | Acceleron Pharma INC | — | EXIT | Sold out |
| 27 | INSM | Insmed INC | — | EXIT | Sold out |
| 28 | ACRS | Aclaris Therapeutics INC | — | NEW | New buy |
| 29 | ✓ | Ignyta INC | — | NEW | New buy |
| 30 | ADMSEUR | Adamas Pharmaceuticals INC | — | EXIT | Sold out |
| 31 | FGENEUR | Fibrogen INC | — | EXIT | Sold out |
| 32 | ✓ | Trevena INC | — | EXIT | Sold out |
| 33 | ✓ | Newlink Genetics CORP | — | EXIT | Sold out |
| 34 | ASND | Ascendis Pharma A/S | — | EXIT | Sold out |
| 35 | ZGNXEUR | Zogenix INC | — | EXIT | Sold out |
| 36 | CNCEEUR | Concert Pharmaceuticals INC | — | EXIT | Sold out |
| 37 | AXSM | Axsome Therapeutics INC | — | NEW | New buy |
| 38 | SGMOQ | Sangamo Therapeutics INC | — | EXIT | Sold out |
| 39 | ✓ | Axovant Sciences LTD | — | NEW | New buy |
| 40 | ✓ | Tigenix | — | NEW | New buy |
| 41 | MRNSUSD | Marinus Pharmaceuticals INC | — | NEW | New buy |
| 42 | ✓ | Axovant Sciences LTD | — | EXIT | Sold out |
| 43 | IMRX | Immuneering Corporation | — | EXIT | Sold out |
| 44 | RDHLGBP | Redhill Biopharma Ltd-sp Adr | — | EXIT | Sold out |
| 45 | ZSANGBP | Zosano Pharma CORP | — | NEW | New buy |
| 46 | ✓ | Intec Pharma LTD Jerusalem | — | EXIT | Sold out |
| 47 | SRRAEUR | Sierra Oncology INC | — | NEW | New buy |
| 48 | ALKS | Alkermes plc | — | NEW | New buy |
| 49 | ✓ | Obseva SA | — | NEW | New buy |
| 50 | ✓ | Amicus Therapeutics INC | — | EXIT | Sold out |